NCT04354428 Treatment for COVID-19 in High-Risk Adult Outpatients Status TERMINATED Phase PHASE2/PHASE3
NCT04351711 Immunological Profiling of Patients With COVID-19 in Respiratory Distress Status COMPLETED Phase N/A
NCT04350086 Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection Status WITHDRAWN Phase PHASE4
NCT04347850 A Cohort of Patients With Possible or Confirmed SARS-CoV-2 (COVID-19) Status UNKNOWN Phase N/A
NCT04347278 Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry Status UNKNOWN Phase N/A
NCT04346797 CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort Status UNKNOWN Phase PHASE2
NCT04346667 Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds Status TERMINATED Phase PHASE4
NCT04345315 Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent. Status UNKNOWN Phase N/A
NCT04345159 Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease Status COMPLETED Phase N/A
NCT04343781 National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19 Status COMPLETED Phase N/A
NCT04341168 Clinical and Immunological Characterisation of COVID-19 in Children, Adolescents and Adults Status UNKNOWN Phase N/A
NCT04339998 Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS) Status COMPLETED Phase N/A
NCT04336332 Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19 Status TERMINATED Phase PHASE2
NCT04335786 Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease Status TERMINATED Phase PHASE4